Srisawad Corporation PCL (BKK:SAWAD)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	32,233	63,062	55,613	66,941	84,792	90,285
Market Cap Growth	-30.35%	13.40%	-16.92%	-21.05%	-6.08%	-1.36%
PE Ratio	6.59	12.48	11.12	14.96	17.96	20.03
PS Ratio	2.09	3.95	3.74	5.91	8.57	9.24
PB Ratio	0.86	1.74	1.78	2.31	3.14	3.75
P/FCF Ratio	2.09	5.93	-	-	32.77	-
P/OCF Ratio	2.07	5.85	-	-	30.67	-
Debt / Equity Ratio	1.77	1.90	2.44	1.26	0.70	0.86
Debt / FCF Ratio	4.31	6.48	-	-	7.33	-
Quick Ratio	3.31	2.92	2.60	2.97	3.24	3.77
Current Ratio	3.39	2.99	2.65	3.06	3.32	3.84
Asset Turnover	0.14	0.14	0.17	0.19	0.19	0.20
Return on Equity (ROE)	14.59%	15.54%	17.46%	17.24%	19.74%	21.65%
Return on Assets (ROA)	4.61%	4.78%	5.81%	8.08%	9.88%	9.83%
Earnings Yield	15.17%	8.01%	8.99%	6.69%	5.57%	4.99%
Earnings Yield	15.17%	8.01%	8.99%	6.69%	5.57%	4.99%
FCF Yield	47.76%	16.86%	-37.26%	-25.06%	3.05%	-1.18%
Dividend Yield	0.19%	0.10%	0.03%	3.82%	3.12%	3.00%
Payout Ratio	0.32%	0.31%	49.42%	55.21%	52.32%	42.63%
Buyback Yield / Dilution	-0.15%	-	0.00%	-	-1.15%	-2.92%
Total Shareholder Return	0.03%	0.10%	0.03%	3.82%	1.97%	0.08%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.